GMED (GMED)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$10.18B
EV / Sales3.28
EV / EBITDA11.57
EV / Operating Cash Flow13.08
EV / Free Cash Flow16.96

Return Metrics (TTM)

Return on Equity (ROE)13.04%
Return on Assets (ROA)10.79%
Return on Invested Capital (ROIC)9.72%
Return on Capital Employed (ROCE)11.02%

Yield Metrics

Earnings Yield5.50%
Free Cash Flow Yield5.65%

Balance Sheet Strength

Net Debt / EBITDA-0.51
Current Ratio4.56
Working Capital$1.72B
Tangible Asset Value$2.57B
Net Current Asset Value$1.49B

Working Capital Efficiency

Days Sales Outstanding86.57
Days Payables Outstanding37.97
Operating Cycle (Days)369.57
Cash Conversion Cycle331.60

Capital Allocation

CapEx / Revenue5.75%
CapEx / Operating Cash Flow22.89%
R&D / Revenue6.08%
SG&A / Revenue44.23%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin67.41%
Operating Margin16.33%
Net Profit Margin18.30%

Solvency

Debt / Equity0.03
Quick Ratio2.74
Cash Ratio1.06

Per Share

Revenue / Share$21.75
FCF / Share$4.36
PE Ratio21.94